4.8 Article

Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial

期刊

CIRCULATION
卷 123, 期 3, 页码 274-281

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.110.963181

关键词

myocardial infarction; angioplasty; stents; tomography, optical coherence; thrombosis

资金

  1. Ospedali Riuniti di Bergamo
  2. University Hospitals
  3. Case Western Reserve University
  4. Cardiovascular Research Foundation
  5. Boston Scientific Corp
  6. Medicines Company (Parsippany, NJ)
  7. LightLab
  8. Boston Scientific
  9. Volcano
  10. LightLab Imaging
  11. Medtronic Vascular
  12. Abbott Vascular
  13. Medtronic
  14. Scitech
  15. Cordis

向作者/读者索取更多资源

Background-The safety of drug-eluting stents in ST-segment elevation myocardial infarction (STEMI) continues to be debated. Pathological studies have demonstrated an association between uncovered struts and subsequent stent thrombosis. Optical coherence tomography can detect stent strut coverage in vivo on a micron-scale level. We therefore used optical coherence tomography to examine strut coverage in patients with STEMI treated with paclitaxel-eluting stents (PES) and bare metal stents (BMS). Methods and Results-In the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial, patients with STEMI were randomized 3: 1 to PES or BMS implantation. In a formal substudy, optical coherence tomography at 13 months was performed in 118 consecutive randomized patients (89 PES, 29 BMS) in whom 188 stents were assessed (146 PES and 42 BMS). A total of 44 139 stent struts were analyzed by an independent core laboratory blinded to stent assignment. The primary prespecified end point, the percentage of uncovered stent struts per lesion at follow-up, was 1.1 +/- 2.5% in BMS lesions versus 5.7 +/- 7.0% in PES lesions (P<0.0001). Malapposed struts were observed in 0.1 +/- 0.2% of BMS lesions versus 0.9 +/- 2.1% of PES lesions (P=0.0003). Percentage net volume obstruction was 36.0 +/- 15.4% with BMS and 19.2 +/- 11.3% with PES (P<0.0001). Conclusions-In patients with STEMI undergoing primary percutaneous coronary intervention, implantation of PES as compared with BMS significantly reduces neointimal hyperplasia but results in higher rates of uncovered and malapposed stent struts as assessed by optical coherence tomography at 13-month follow-up. Further studies are required to determine the clinical significance of these findings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据